Table 15.4a

Steroid Avoidance Rate at Discharge, 1995 to 2004

Recipients of Deceased Donor Kidneys

Discharge Regimen Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Total Patients 6,112 6,142 6,311 6,524 6,480 6,401 6,702 6,981 7,137 7,531
Steroids Avoided 383 169 161 211 167 258 348 520 982 1,493
Rate 6.3% 2.8% 2.6% 3.2% 2.6% 4.0% 5.2% 7.4% 13.8% 19.8%
CyA Patients 719 561 421 384 348 214 105 92 105 114
Steroids Avoided 24 17 23 22 16 4 3 3 11 12
Rate 3.3% 3.0% 5.5% 5.7% 4.6% 1.9% 2.9% 3.3% 10.5% 10.5%
Tac Patients 160 200 187 176 196 237 337 399 221 271
Steroids Avoided 7 3 3 9 11 34 83 158 65 87
Rate 4.4% 1.5% 1.6% 5.1% 5.6% 14.3% 24.6% 39.6% 29.4% 32.1%
CyA+MMF Patients 679 2,457 3,240 3,346 3,162 2,524 1,969 1,774 1,516 1,268
Steroids Avoided 6 39 32 40 31 45 44 43 97 108
Rate 0.9% 1.6% 1.0% 1.2% 1.0% 1.8% 2.2% 2.4% 6.4% 8.5%
Tac+MMF Patients 41 336 735 1,169 1,641 1,990 2,621 3,334 3,748 4,571
Steroids Avoided 1 9 19 24 36 53 76 126 401 904
Rate 2.4% 2.7% 2.6% 2.1% 2.2% 2.7% 2.9% 3.8% 10.7% 19.8%
CyA+Aza Patients 3,662 1,408 906 577 366 233 120 56 33 14
Steroids Avoided 8 15 10 5 0 1 0 1 2 0
Rate 0.2% 1.1% 1.1% 0.9% 0.0% 0.4% 0.0% 1.8% 6.1% 0.0%
Tac+Aza Patients 102 137 141 122 79 54 85 60 48 26
Steroids Avoided 1 1 2 4 1 1 1 1 1 1
Rate 1.0% 0.7% 1.4% 3.3% 1.3% 1.9% 1.2% 1.7% 2.1% 3.8%
Siro+MMF Patients - - - 2 9 85 257 273 211 205
Steroids Avoided - - - 2 0 5 15 19 35 50
Rate - - - 100.0% 0.0% 5.9% 5.8% 7.0% 16.6% 24.4%
CyA+Siro Patients 6 64 123 220 120 302 292 187 224 209
Steroids Avoided 0 5 0 1 4 2 11 9 55 92
Rate 0.0% 7.8% 0.0% 0.5% 3.3% 0.7% 3.8% 4.8% 24.6% 44.0%
Tac+Siro Patients - - - - 11 300 453 339 438 321
Steroids Avoided - - - - 0 30 56 73 117 104
Rate - - - - 0.0% 10.0% 12.4% 21.5% 26.7% 32.4%
Other Regimen Patients 743 979 558 528 548 462 463 467 593 532
Steroids Avoided 336 80 72 104 68 83 59 87 198 135
Rate 45.2% 8.2% 12.9% 19.7% 12.4% 18.0% 12.7% 18.6% 33.4% 25.4%


Source: OPTN/SRTR Data as of May 2, 2005.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressivedrug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine;Siro: Sirolimus.